Home | Articles
Published on:December 2019
Indian Journal of Pharmaceutical Education and Research, 2020; 54(1):95-100
Original Article | doi:10.5530/ijper.54.1.11

Protective Effect of Capsaicin against Doxorubicin Induced Cardiotoxicity in Experimental Rats


Authors and affiliation (s):

Sanjiv Karale*, Yamuna PV, Jagadish V Kamath

Department of Pharmacology, Shree Devi College of Pharmacy, Mangalore, Karnataka, INDIA.

Abstract:

Aim: The aim of the present study was to evaluate the Cardioprotective effect of Capsaicin (CAP) against Doxorubicin (DOX) induced cardiotoxicity in experimental rats. Methods: The 24 wistar rats were randomly divided into four groups (with equal numbers): Normal- 1% Dimethyl Sulfoxide (DMSO), DOX (15 mg/kg, i.p), CAP (10 mg/kg, p.o, alone) and CAP 10 mg/kg (in combination with DOX). Cardiotoxicity was induced in wistar rats by administering DOX with a cumulative dose of 15 mg/kg (i.p) for 2 weeks. CAP with a dose of 10 mg/kg was administered in respective groups for 21 days. The influence of the treatment was analysed by quantification of serum biomarkers and antioxidants, electrocardiographic parameters and histopathological observations. Results: In the current study, the activities of Lactate Dehydrogenase (LDH), Creatine Kinase-NAC (CKNAC), Creatine Kinase-MB (CK-MB), were reduced (P<0.001) in serum and Superoxide Dismutase (SOD), Reduced Glutathione (GSH) and Catalase activities were increased (P<0.001) in heart tissue homogenate in all treated groups compared to DOX group. Similarly, the electrocardiographic changes were restored close to normal in all treated groups. Results were further supported by histopathological studies. Conclusion: The results reveal that CAP possesses potential benefits against cardiotoxicity induced by DOX by supressing serum markers and oxidative stress in heart tissues of experimental rats.

Key words: Cardiotoxicity, Capsaicin, Doxorubicin, Electrocardiogram, LDH, GSH.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2023 Journal Citation Reports® (Clarivate Analytics, 2023): 0.8

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs